55 Small Cap Stocks Just Made New 52-Week Highs
A cluster of banks and a biotech sprinter mark today’s list of strongest small caps.
While the S&P 500 returned +3.4% over the last month, AbCellera Biologics (ABCL) gained 84.7%. It is one of 55 Small Cap stocks from the Russell 3000 trading at a 52-week high as of Friday, August 14.
The list is heavy with Regional Banks, an industry in the Financials sector with 13 names making new highs. The central question is what kind of business strength, if any, underpins these prices. Below are the names.
The Biggest Names On The List
- How Will Toll Brothers Stock React To Its Upcoming Earnings?
- How Will Keysight Technologies Stock React To Its Upcoming Earnings?
- How Will Home Depot Stock React To Its Upcoming Earnings?
- The Premium On ConocoPhillips Keeps Growing. So Does The Case For Diamondback Energy and EQT
- Phillips 66 Stock Rides A 5-Day Winning Streak To A 15% Gain
- A 5-Day Winning Streak Has SanDisk Stock Up 35%
The table below shows the 10 largest of the 55 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| OSCR | $9.8 Bil | 6.4% | 17.4% | 13.5% | 119.4% |
| LLYVA | $9.7 Bil | 0.8% | 6.3% | 7.3% | 16.1% |
| VOYA | $9.5 Bil | 0.4% | 0.1% | 0.9% | 39.2% |
| JXN | $9.4 Bil | 0.7% | 4.1% | 7.7% | 45.1% |
| NEU | $9.0 Bil | 1.5% | 8.1% | 24.6% | 26.4% |
| CRNX | $8.8 Bil | 0.3% | 0.7% | 0.9% | 181.5% |
| BOKF | $8.8 Bil | 0.3% | 1.6% | 2.1% | 40.7% |
| MHK | $8.6 Bil | 0.7% | 3.0% | 22.2% | 5.6% |
| VCTR | $7.5 Bil | 0.1% | 9.3% | 17.6% | 69.4% |
| ACA | $7.1 Bil | 0.3% | 0.4% | 0.3% | 45.3% |
But is every high built on growth?
Consider the contrast between two names here. Oscar Health (OSCR), the largest company on the list, saw its revenue grow 42.8% over the last twelve months and trades at 18.0 times trailing earnings.
In contrast, NewMarket (NEU) reached its high even as its revenue declined 1.3% over the same period. NewMarket does, however, post a 20.0% operating margin.
A high price is a question, not an answer.
A 52-week-high list is a map of strength, and strong stocks often continue to perform. But a price is not a verdict on a business. The disciplined move is to treat this list as a starting point for research. The real work is determining whether the underlying business fundamentals justify the market’s appraisal.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 26 of the 55 names are Financials stocks. When a whole group is making new highs together, a financials ETF like XLF is one way to own the group’s strength without betting on which single name leads it from here.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Use the high list for ideas; use the portfolio for the compounding.